United States physician Expected to start
|
|
United States physician Expected to start
The vaccine forSLOT XOchildren promotions, which our website has organized these activities. To make profits for members and make the members have fun to enter the game Online betting is increasing.ages 5 to 11 appears to be available in the first half of November. In the opinion of Dr Anthony Fauci, senior US infectious disease expert on Sunday (Oct. 24), the estimated time frame That may see more children get their vaccines before the end of the year.
“If everything goes well And we have been approved by regulators and advised by the CDC. It is more or less likely that children aged 5 to 11 will have access to the vaccine during the first or second week of November,” Fauci told Live Science. ABC news program this week.
U.S. Food and Drug Administration (FDA) officials are investigating the Pfizer/Biotech claim. to obtain approval for the use of two doses of the vaccine in young children An external advisory panel is scheduled to consider its conclusions on October 26.
Usually the US Food and Drug Administration. They often follow the advice of an external advisory panel. However, they are not required to follow such advice.
The U.S. Centers for Disease Control and Prevention (CDC) advisory panel will review recommendations for vaccination for children aged 5 to 11 at the Nov. 2 and 3 meetings to inform Rochelle Valensky's final decision. Director of CDC
Valenski, speaking to Fox News, Sunden also said: Her agency wants to act quickly. “After they (FDA) review all the scientific data and take regulatory action, the CDC will then open a meeting. and if all goes well We will act quickly,” she said.
“We know how many parents are interested in vaccinating their children and grandchildren between the ages of five and 11 and we are committed to doing so as quickly as possible,” Valenski said.
Once approved, approximately 28 million children in the United States will be eligible for the so-called COVID-19 vaccination. to young children for the first time in the United States. The Pfizer/Biotech vaccine was previously approved for children between the ages of 12 and 17, and the company continues to study the vaccine in children under five. |
|
|
|
|
|
